Effect of sparsomycin in vivo and in vitro on hepatic polyribosomes and protein synthesis.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D002250:Carbon Radioisotopes; D002474:Cell-Free System; D002499:Centrifugation, Density Gradient; D003513:Cycloheximide / Q000494:pharmacology; D066298:In Vitro Techniques; D008099:Liver / Q000166:cytology*; D008297:Male; D008715:Methionine / Q000378:metabolism; D051379:Mice; D010442:Peptide Chain Initiation, Translational / Q000187:drug effects; D010448:Peptide Initiation Factors / Q000494:pharmacology; D010649:Phenylalanine; D011132:Polyribosomes / Q000187:drug effects*; D014176:Protein Biosynthesis; D012343:RNA, Transfer; D012263:Ribonucleosides / Q000494:pharmacology; D013395:Sucrose; D013997:Time Factors
D000903:Antibiotics, Antineoplastic; D002250:Carbon Radioisotopes; D010448:Peptide Initiation Factors; D012263:Ribonucleosides; D010649:Phenylalanine; D013395:Sucrose; D012343:RNA, Transfer; D003513:Cycloheximide; D008715:Methionine